Announcements Trials
Browse Landscape

Phase

Phase 3 6Phase 2 6Phase 1 4Phase NA 3Phase 1/2 2

Status

Terminated 2Withdrawn 1Active not recruiting 1

Sponsor Class

UNKNOWN 2OTHER_GOV 1OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Head & Neck 2CNS 1Breast 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Mouth Neoplasms 1Glioblastoma 1Breast Neoplasms 1Advanced Cancer 1

Interventions

Cyclophosphamide 624pembrolizumab 500Paclitaxel 456Gemcitabine 438Carboplatin 435Cisplatin 418Radiotherapy 380fludarabine 365Nivolumab 340Docetaxel 277Bevacizumab 276Irinotecan 257Magnetic Resonance Spectroscopy 242Fluorouracil 228Dexamethasone 225Specimen Handling 221Capecitabine 218Rituximab 205Cytarabine 201Oxaliplatin 200Ipilimumab 199Temozolomide 197Biopsy 196fludarabine phosphate 194Etoposide 181Lenalidomide 176Doxorubicin 175Leucovorin 173Cetuximab 171Injections 170

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × nabiximols × Clear all
NCT05969314 2025-04-11

To Check Safety of Ayurvedic Oral Cannabis in Breast and Head and Neck Cancer

Tata Memorial Hospital

Phase 1 Active not recruiting
12 enrolled
BreastHead & Neck

Breast Neoplasms, Mouth Neoplasms

NCT03246113 2019-08-13

Tolerability of Cannabis in Patients Receiving Concurrent Chemoradiation for Glioblastoma

New York State Psychiatric Institute

Phase 1 Terminated
1 enrolled
CNS

Glioblastoma

NCT01975688 2016-08-11

A Pharmacokinetic Study of Single Doses of Sativex in Treatment-induced Mucositis

GWPharm

Phase 1 Terminated
10 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT02432612 2016-03-02

A Study to Assess the Pharmacokinetic (PK) Properties of Sativex® in Patients With Advanced Cancer

GWPharm

Phase 1 Withdrawn

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡